EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Optimization and Characterization of Chlorthalidone Bilayer Tablets for Chronotherapeutic Pulsatile Drug Release

Moulindu Mondal, Deepannita Roy Mukherjee, Dona Biswas, Pinki Biswas, Saikat Santra

Journal of Drug Delivery and Therapeutics · 15.06.2026 · 16 (6) · 127-138

DOI: 10.22270/jddt.v16i6.7813 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Drug Delivery and Therapeutics, online erschienen am 15.06.2026. Verfasst von Moulindu Mondal und 4 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulsatile Drug Delivery System (PDDS) is defined as the rapid and transient release of drug molecules within a short time period immediately after a predetermined lag (off release) period. Blood pressure exhibits a well-documented circadian surge in the early morning hours — a window associated with peak cardiovascular morbidity. Chlorthalidone, a BCS Type-II thiazide-like diuretic with a plasma half-life of 40–60 hours, was selected as the model drug for a chronopharmacological pulsatile formulation. Nine bilayer press-coated tablet formulations (CHT-A through CHT-I) were prepared using Hydroxypropyl Methylcellulose K100M (HPMC) as the hydrophilic swelling polymer and Ethyl Cellulose (EC) as the hydrophobic rupturable membrane at varying weight ratios. Preformulation studies — including ATR-IR spectroscopy, Differential Scanning Calorimetry (DSC), and powder flow characterization — confirmed drug identity, thermal behaviour, and excipient compatibility. Scanning Electron Microscopy (SEM) was employed to characterize surface morphology. The core tablet exhibited a disintegration time of 185 seconds and 95.8% drug content. Formulation CHT-G (HPMC 150 mg: EC 250 mg) demonstrated the optimal 6-hour lag time followed by a burst release of 83.20% at hour 7. Korsmeyer-Peppas modelling (R² = 0.8545; n = 2.2082) identified super case-II swelling-controlled transport as the dominant release mechanism. The developed system offers a clinically promising chronopharmacological strategy for the management of morning-surge hypertension. Keywords: Pulsatile Drug Delivery; Chlorthalidone; Bilayer Tablet; HPMC; Ethyl Cellulose; DSC; SEM; Lag Time; Chronopharmacology; Hypertension

Zitieren

APA

Mondal, M., Mukherjee, D. R., Biswas, D., Biswas, P., & Santra, S. (2026). Optimization and Characterization of Chlorthalidone Bilayer Tablets for Chronotherapeutic Pulsatile Drug Release. Journal of Drug Delivery and Therapeutics, 16(6), 127-138. https://doi.org/10.22270/jddt.v16i6.7813

Vancouver

Mondal M, Mukherjee DR, Biswas D, Biswas P, Santra S. Optimization and Characterization of Chlorthalidone Bilayer Tablets for Chronotherapeutic Pulsatile Drug Release. Journal of Drug Delivery and Therapeutics. 2026;16(6):127-138. doi:10.22270/jddt.v16i6.7813

BibTeX
@article{Mondal2026,
  author = {Mondal, Moulindu and Mukherjee, Deepannita Roy and Biswas, Dona and Biswas, Pinki and Santra, Saikat},
  title = {Optimization and Characterization of Chlorthalidone Bilayer Tablets for Chronotherapeutic Pulsatile Drug Release},
  journal = {Journal of Drug Delivery and Therapeutics},
  year = {2026},
  volume = {16},
  number = {6},
  pages = {127--138},
  doi = {10.22270/jddt.v16i6.7813}
}
Kostenlos starten →